Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News 23andMe Holding Co. ME

Consumer Cyclical Healthcare Advertising Agencies
23andMe Holding Co. is a genetics-led consumer healthcare and therapeutics company. The Company operates through two segments: Consumer & Research Services and Therapeutics. The Consumer & Research Services business segment comprises its Personal Genome Service (PGS), telehealth business, and research service. PGS services provide customers with a broad suite of genetic reports, including... see more

Recent & Breaking News (NDAQ:ME)

INVESTIGATION ALERT: Levi & Korsinsky, LLP Announces Investigation Of 23andMe Holding Co (ME) Data Breach

Newsfile December 7, 2023

INVESTIGATION ALERT: Levi & Korsinsky, LLP Announces Investigation Of 23andMe Holding Co (NASDAQ: ME) Data Breach

Accesswire December 6, 2023

INVESTIGATION ALERT: Levi & Korsinsky, LLP Announces Investigation Of 23andMe Holding Co (NASDAQ: ME) Data Breach

PR Newswire December 5, 2023

INVESTIGATION ALERT: Levi & Korsinsky, LLP Announces Investigation Of 23andMe Holding Co (NASDAQ: ME) Data Breach

Accesswire December 4, 2023

PRIVACY ALERT: Genetic Testing Company 23andMe Faces Class Action Investigation for Cyberattack Potentially Impacting Five Million Customers

PR Newswire November 13, 2023

23andMe Reports Second Quarter Fiscal 2024 Financial Results

GlobeNewswire November 8, 2023

23andMe Launches Total Health(TM), its Comprehensive, Prevention-Based Health Membership

GlobeNewswire November 7, 2023

23andMe Announces Updated Safety and Preliminary Efficacy Data From the Phase 1/2a Study of 23ME-00610, an Investigational Antibody Targeting CD200R1

GlobeNewswire November 6, 2023

23andMe Launches Health Action Plan to Provide Personalized Recommendations Based on Genetic and Other Health Data

GlobeNewswire October 31, 2023

23andMe Announces Collaboration Extension with a New Data Licensing Agreement with GSK

GlobeNewswire October 30, 2023

23andMe to Report FY2024 Second Quarter Financial Results

GlobeNewswire October 25, 2023

23andMe Announces Poster Presentations on 23ME-00610, an Investigational Antibody Targeting CD200R1, at The Society for Immunotherapy of Cancer's (SITC) 2023 Annual Meeting

GlobeNewswire September 27, 2023

23andMe and Sickle Cell 101 Collaborate to Expand Sickle Cell Awareness Program

GlobeNewswire September 14, 2023

23andMe Granted New FDA Clearance to Report Additional BRCA Variants

GlobeNewswire August 31, 2023

23andMe Reports FY2024 First Quarter Financial Results

GlobeNewswire August 8, 2023

SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Is Investigating 23andMe Holding Co. for Potential Breaches of Fiduciary Duty By Its Board of Directors

PR Newswire July 31, 2023

23andMe to Report FY2024 First Quarter Financial Results

GlobeNewswire July 25, 2023

23andMe Releases New FDA-Cleared Genetic Report on Simvastatin, a Commonly Prescribed Statin

GlobeNewswire July 20, 2023

23andMe Releases New Report Revealing Genetic Likelihood of Experiencing Panic Attacks

GlobeNewswire June 21, 2023

23andMe Reports FY2023 Fourth Quarter and Full Year Financial Results

GlobeNewswire May 25, 2023